Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

The Technische Universitat Dresden patents novel antibodies for cancer

Jan. 31, 2013

Huabo Biopharm divulges novel bifunctional fusion proteins

Jan. 31, 2013

Limited efficacy seen for ganetespib in patients with HCC

Jan. 31, 2013

Biotecnol and Chiome to codevelop antibodies for cancer

Jan. 30, 2013

Kissei seeks Japanese approval of dexrazoxane for use in anthracycline extravasation

Jan. 30, 2013

4-Antibody and the Ludwig Institute expand oncology antibody program

Jan. 30, 2013

Combination of luminespib and capecitabine well tolerated

Jan. 30, 2013

CNRS discloses novel antibodies for cancer and other disorders

Jan. 30, 2013

Results presented from phase II trial of axitinib in hepatocellular carcinoma

Jan. 30, 2013

Trametinib dimethyl sulfoxide plus gemcitabine does not improve outcomes in pancreatic cancer

Jan. 30, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...